Table 3 Top ten genera by prevalence stratified by clinical state

From: Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

  Rank Genus Mean (%) Median (%) Stdev Prev. (%) RA rank Hub rank Metab.a
Baseline 1 Prevotella 12.537 6.257 15.089 100.0 2 4
2 Rothia 6.383 2.002 13.623 100.0 4 54
3 Streptococcus 9.705 5.769 11.204 98.8 3 10 +
4 Actinomyces 2.419 0.666 4.089 98.8 8 19
5 Veillonella 3.455 1.460 4.994 95.0 6 2
6 Gemella 1.528 0.393 2.769 95.0 11 11 +/−
7 Pseudomonas 41.289 46.880 36.709 92.5 1 5 +
8 Stenotrophomonas 6.289 0.023 20.681 92.5 5 23 +
9 Staphylococcus 1.076 0.011 4.598 90.0 14 41 +/−
10 Solobacterium 0.485 0.041 1.034 85.0 18 25
Unwell 1 Streptococcus 12.074 5.016 14.122 98.8 3 25 +
2 Rothia 5.884 1.776 12.203 98.2 5 14
3 Prevotella 15.143 6.885 19.744 96.5 2 16
4 Veillonella 4.898 0.886 8.430 93.6 6 11
5 Actinomyces 2.138 0.217 4.041 93.0 9 19
6 Stenotrophomonas 9.389 0.096 18.196 87.7 4 9 +
7 Pseudomonas 30.790 13.553 34.454 84.2 1 6 +
8 Staphylococcus 2.631 0.015 9.910 81.3 8 99 +/−
9 Gemella 1.306 0.020 3.857 81.3 13 12 +/−
10 Solobacterium 0.499 0.035 1.812 72.5 16 4
PE 1 Streptococcus 14.127 9.869 13.198 100.0 2 22 +
2 Prevotella 9.927 7.086 12.885 100.0 3 9
3 Rothia 6.466 0.480 15.744 100.0 4 35
4 Haemophilus 4.755 0.023 17.451 100.0 6 52 +/−
5 Veillonella 2.894 1.069 3.511 100.0 8 11
6 Actinomyces 2.311 0.517 3.661 100.0 9 1
7 Staphylococcus 0.474 0.099 0.984 100.0 17 36 +/−
8 Neisseria 0.228 0.014 0.488 100.0 26 23 +
9 Pseudomonas 36.645 33.068 36.134 93.8 1 30 +
10 Stenotrophomonas 2.275 0.092 5.406 93.8 10 29 +
  1. Prev. prevalence, RA relative abundance
  2. aMetab. = Metabolism: + aerobic, − anaerobic, +/− facultative anaerobic